focus -WSS

focus

author：entertainment 2025-09-28 20:33:10 - browse：7

Monica Bertagnolli -- Health Policy coverage from STAT — Monica Bertagnolli, the nominee to lead the National Institutes of Health Jeff Chiu/AP

Monica Bertagnolli, President Biden’s nominee to lead the National Institutes of Health, spent her confirmation hearing Wednesday stuck in the middle of Republicans’ and Democrats’ bickering over her agency’s role in high drug costs, ultimately refusing to commit to either party’s approach.

Bertagnolli similarly walked a line on government funding for gender-affirming care research and other hotly politicized health care issues, though she did stress that transgender youth are some of the country’s most vulnerable people.

The long-awaited hearing came months after Committee Chairman Bernie Sanders (I-Vt.) pledged to stall her confirmation process until Biden did more to address high drug prices, like an assurance that the NIH would insert reasonable pricing requirements into deals with commercial drugmakers.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： Physician executives need more than on

entertainment

WSS

Boston man files lawsuit seeking to bankrupt white supremacist group he says assaulted him

Senate panel eyes new effort on drug shortages

Discs beat pads, tampons for heavy menstrual flow, new study shows

Stroke deaths set to near 10 million globally by 2050

'Of course' Trump lost the 2020 election, DeSantis says after years of hedging

Sana to lay off nearly a third of staff, de

focus

focus

explore

Wildfire smoke exposes gaps in outdoor worker protections

CDC launches VaccineFinder tool to locate Covid

Heart attack and stroke risk calculators need revising

Why Charlie Gard's case is so disturbing to Americans

Trump demands the U.S. pay no more for drugs than other countries … again

Sana to lay off nearly a third of staff, de

Tori Bowie and the unacceptable rates of Black maternal death

Choosing scientific sides in the fight against Alzheimer's

Peter Hotez and the public health issue of online harassment

Was Amgen transparent enough on FDA's concern on cancer drug?

knowledge

FTX founder Sam Bankman

Analysis of telehealth claims data suggest service duplication

Chan Zuckerberg Biohub Chicago to focus on inflammation

Bill would stop addiction treatment from triggering child abuse inquiry

Senate panel eyes new effort on drug shortages

Why Charlie Gard's case is so disturbing to Americans

explore

hotspot

entertainment

hotspot